BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24531562)

  • 1. Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt.
    Schmid CL; Streicher JM; Meltzer HY; Bohn LM
    Neuropsychopharmacology; 2014 Jul; 39(8):1902-13. PubMed ID: 24531562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation.
    Raote I; Bhattacharyya S; Panicker MM
    Mol Pharmacol; 2013 Jan; 83(1):42-50. PubMed ID: 23034456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
    Schmid CL; Raehal KM; Bohn LM
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. His452Tyr polymorphism in the human 5-HT
    Martín-Guerrero SM; Alonso P; Iglesias A; Cimadevila M; Brea J; Loza MI; Casado P; Martín-Oliva D; Cutillas PR; González-Maeso J; López-Giménez JF
    Biochem Pharmacol; 2021 Mar; 185():114440. PubMed ID: 33539816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.
    Schmid CL; Bohn LM
    J Neurosci; 2010 Oct; 30(40):13513-24. PubMed ID: 20926677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAGI proteins can differentially regulate the signaling pathways of 5-HT
    Hammad MM; Dunn HA; Ferguson SSG
    Cell Signal; 2018 Jul; 47():109-121. PubMed ID: 29625175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
    Andressen KW; Manfra O; Brevik CH; Ulsund AH; Vanhoenacker P; Levy FO; Krobert KA
    Br J Pharmacol; 2015 Aug; 172(15):3846-60. PubMed ID: 25884989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT
    Aringhieri S; Kolachalam S; Gerace C; Carli M; Verdesca V; Brunacci MG; Rossi C; Ippolito C; Solini A; Corsini GU; Scarselli M
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):383-398. PubMed ID: 28283227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of 5-HT
    Lin H; Kim JG; Park SW; Noh HJ; Kim JM; Yoon CY; Woo NS; Kim B; Il Cho S; Choi BH; Sung DJ; Bae YM
    Exp Mol Med; 2018 Apr; 50(4):1-8. PubMed ID: 29700292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT
    García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimavanserin exhibits serotonin 5-HT
    Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
    Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.
    Kargieman L; Riga MS; Artigas F; Celada P
    Neuropsychopharmacology; 2012 Feb; 37(3):723-33. PubMed ID: 22012474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
    Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
    Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.
    Williams AA; Ingram WM; Levine S; Resnik J; Kamel CM; Lish JR; Elizalde DI; Janowski SA; Shoker J; Kozlenkov A; González-Maeso J; Gallitano AL
    Neuropsychopharmacology; 2012 Sep; 37(10):2285-98. PubMed ID: 22692564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.